Resources

In two Newscasts time, we will know the outcome of the UK General Election to be held on Thursday, 4 July. Join our webinar tomorrow at 1 pm where we will discuss what we have learned from the campaigns and manifestoes about potential future policies and people important for our sector after the result.

A new spin-out company is set to transform the agricultural sector by revolutionising plant and animal breeding, as well as the development of inputs such as agrochemicals, biostimulants, biologicals, and plant nutrients.

Why to channel Scottish polymath Mary Somerville, how timing can make or break a startup, and other lessons from experts at All You Can Innovate 2024.

Notice of Allowance for Immunomodulator II further strengthens robust intellectual property portfolio

This Thursday marks Rare Disease Day, and as it is a leap year it is taking place on the rarest day of all – 29 February. There are 3.5 million people in the UK living with a rare condition and one in 17 people will be affected by a rare condition at some point in their lives.

I'm looking forward to the BIA Committee Summit this week. It will be great to see 200 members in Westminster at one of the most lively and insightful events we do each year. I know it's the volunteer expert army that gives the BIA its unique impact with government and it's always great to understand the committee's priorities and the ideas at the intersection between committees that arise from the event.

The BIA’s Intellectual Property Advisory Committee (IPAC) helps BIA understand and shape the environment for IP ownership to ensure strong protection for BIA member companies. Our EU policy subcommittee has taken a look at what a recent European decision means for the right to claim priority to an earlier filed patent application. This blog sets out some of the details of the case, and the practical implications for BIA members.​​​​​​​

The BIA AGM, our new TechBio 2023 report, MSD break ground in London, a warning from MI5 and pandemic treaty developments. 

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments for millions of women worldwide.

The UK’s science minister has praised a decade of growth at Discovery Park, the leading science and innovation campus in Sandwich, Kent.

With Acro Certify, ACROBiosystems offers a ‘bridge’ to help cross this chasm. When it comes to developing the right ‘Go-to-Market’ strategy, Acro Certify helps tailor a strategic plan targeting each region to optimize product success.

The techbio company PrecisionLife announces it has reached a data access and licensing agreement with King’s College London to enable it to generate and commercialize novel insights into Motor Neurone Disease (MND).